The impact of Bacille Calmette-Guérin shortage on immunisation practice and policies in Europe – A Paediatric Tuberculosis Network European Trials Group (ptbnet) survey - 20/04/17
, Begoña Santiago c , Marc Tebruegge d, e, f , Ulrich von Both g, h , Eeva Salo a , Nicole Ritz f, i, ⁎ Ptbnet BCG shortage project collaborators, on behalf of the Paediatric Tuberculosis Network European Trials Group (ptbnet)
on behalf of the
Paediatric Tuberculosis Network European Trials Group (ptbnet)
Summary |
Background |
Recent reports indicate an ongoing BCG shortage that may influence immunisation practice. This study aimed to determine current availability of BCG vaccine across Europe, and implications on immunisation practices and policies in Europe.
Methods |
Web-based survey among Paediatric Tuberculosis Network European Trials Group (ptbnet) members, between May and October 2015.
Results |
Twenty individuals from 13 European countries participated. Ongoing shortages were reported in eight countries routinely using BCG (8/11, 73%). As a consequence of the shortage, BCG was not given as completely unavailable in some countries (2/8, 25%), was given only whenever available (1/8, 13%), or only in certain regions of the country (1/8, 13%). Strategies reported to reduce loss of immunisation were administration to selected high-risk individuals (2/8, 25%), or cohorting vaccinees on specific days to maximise the use of multi-dose vials (3/8, 38%). Authorities in two countries each were considering a change of manufacturer/supplier (2/8, 25%).
Conclusions |
The BCG shortage in Europe leads to significant changes in immunisation policies including changes of BCG vaccine strain and manufacturer. In addition, infants and children eligible for immunisation are at risk of not receiving BCG. To ensure necessary BCG immunisations, collaboration between national health agencies and vaccine manufacturers is crucial.
Le texte complet de cet article est disponible en PDF.Keywords : Tuberculosis, TB, BCG, Supply, Public health, Vaccine
Abbreviations : AE, BCG, ECDC, TB, MDR, ptbnet, SSI, UNICEF, WHO, XDR
Plan
| ☆ | Prior publication: Some of the data from the survey was published as an abstract at the 34th Annual Meeting of the European Society for Paediatric Infectious Diseases, 2016. |
Vol 101
P. 125-129 - décembre 2016 Retour au numéro
Article précédent
- Relating annual migration from high tuberculosis burden country of origin to changes in foreign-born tuberculosis notification rates in low-medium incidence European countries
- Aidan Hanway, Catherine M. Comiskey, Katy Tobin, Ronan F. O'Toole
- Quick and cheap MIRU-VNTR typing of Mycobacterium tuberculosis species complex using duplex PCR
- Memona Yasmin, Stéphanie Le Moullec, Rubina Tabassum Siddiqui, Jessica De Beer, Christophe Sola, Guislaine Refrégier
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?